{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:26:01Z","timestamp":1793643961824,"version":"4.5.1"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2025\/03\/34290"],"award-info":[{"award-number":["PSAU\/2025\/03\/34290"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cca.2026.120839","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:03:22Z","timestamp":1768323802000},"page":"120839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["GDF-15 as an integrative cardiometabolic biomarker"],"prefix":"10.1016","volume":"583","author":[{"given":"Obaid","family":"Afzal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaid Hussain","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Altharawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak A.","family":"Alamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal A.","family":"Alossaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmalik S.A.","family":"Altamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavan","family":"Goud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cca.2026.120839_bb0005","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.numecd.2024.09.004","article-title":"Organisational initiatives to improve care in the prevention and management of cardiometabolic conditions: a scoping review","volume":"34","author":"Habte-Asres","year":"2024","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12902-024-01561-0","article-title":"Evaluation of the prevalence of cardiometabolic disorders (diabetes, hypertension, and hyperlipidemia) diagnosed, undiagnosed, treated, and treatment goal in the elderly: Bushehr elderly health program (BEH)","volume":"24","author":"Ebrahimpur","year":"2024","journal-title":"BMC Endocr. Disord."},{"issue":"14","key":"10.1016\/j.cca.2026.120839_bb0015","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.scib.2025.05.017","article-title":"Intermittent fasting and cardiovascular health: a circadian rhythm-based approach","volume":"70","author":"Zhang","year":"2025","journal-title":"Sci. Bull. (Beijing)"},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70878","article-title":"Advancements in biomarkers for early detection and risk stratification of cardiovascular diseases-a literature review","volume":"8","author":"Nazir","year":"2025","journal-title":"Health Sci. Reports"},{"issue":"9","key":"10.1016\/j.cca.2026.120839_bb0025","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/jcmm.17725","article-title":"Overview of growth differentiation factor 15 in metabolic syndrome","volume":"27","author":"Asrih","year":"2023","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cca.2026.120839_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103016","article-title":"M2 macrophage exosome-derived lncRNA AK083884 protects mice from CVB3-induced viral myocarditis through regulating PKM2\/HIF-1\u03b1 axis mediated metabolic reprogramming of macrophages","volume":"69","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.cca.2026.120839_bb0035","series-title":"Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases, Research (Washington, D.C.)","first-page":"0832","volume":"vol. 8","author":"Tian","year":"2025"},{"issue":"7","key":"10.1016\/j.cca.2026.120839_bb0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/biom15070991","article-title":"Growth differentiation factor 15 predicts cardiovascular events in peripheral artery disease","volume":"15","author":"Li","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.cca.2026.120839_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1396133","article-title":"GDF-15 is a potential candidate biomarker for an elevated risk of cardiotoxicity in breast cancer patients receiving neoadjuvant dual anti-HER2 therapy","volume":"15","author":"Tian","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.cca.2026.120839_bb0050","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/labmed\/lmae045","article-title":"Integrated biomarker profiling for enhanced heart failure management: a comprehensive study on the application of chemiluminescence detection of GDF-15 and multi-index models","volume":"55","author":"Zhang","year":"2024","journal-title":"Lab. Med."},{"key":"10.1016\/j.cca.2026.120839_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117225","article-title":"A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)","volume":"178","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0060","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/clc.23159","article-title":"Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: a meta-analysis of prospective studies","volume":"42","author":"Xie","year":"2019","journal-title":"Clin. Cardiol."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041130","article-title":"Expression of the novel cardiac biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF patients compared to ICM, DCM, and controls","volume":"9","author":"Jirak","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0070","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1021\/acsnano.3c05847","article-title":"Multitargeted immunomodulatory therapy for viral myocarditis by engineered extracellular vesicles","volume":"18","author":"Pei","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.cca.2026.120839_bb0075","article-title":"Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: potential role in cardiovascular diseases","volume":"9","author":"di Candia","year":"2021","journal-title":"American Heart J. Plus\u202f: Cardiology Res. Practice"},{"issue":"11","key":"10.1016\/j.cca.2026.120839_bb0080","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1515\/cclm-2022-0135","article-title":"Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort","volume":"60","author":"Welsh","year":"2022","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0085","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/s41467-024-49366-y","article-title":"Total and H-specific GDF-15 levels increase in caloric deprivation independently of leptin in humans","volume":"15","author":"Chrysafi","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cca.2026.120839_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148709","article-title":"GDF-15 is elevated in children with mitochondrial diseases and is induced by mitochondrial dysfunction","volume":"11","author":"Montero","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.120839_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2025.112117","article-title":"The stress-responsive cytokine GDF-15 and sarcopenia: a systematic review and meta-analysis on aging muscle decline","volume":"228","author":"Papa","year":"2025","journal-title":"Mech. Ageing Dev."},{"issue":"8","key":"10.1016\/j.cca.2026.120839_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14082764","article-title":"Association of Circulating GDF-15 with Fetal growth in gestational diabetes","volume":"14","author":"Filardi","year":"2025","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0105","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11010-023-04782-4","article-title":"Hyperactive behaviour of growth differentiation factor- 15 (GDF-15) in conjunction with iron trafficking transporters and suppression of Nrf-2 gene in diabetes and metabolic syndrome","volume":"479","author":"Saroj","year":"2024","journal-title":"Mol. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.cca.2026.120839_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac405","article-title":"DGHNE: network enhancement-based method in identifying disease-causing genes through a heterogeneous biomedical network","volume":"23","author":"He","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.cca.2026.120839_bb0115","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2023-0416","article-title":"GDF-15 levels in patients with polycystic ovary syndrome treated with metformin: a combined clinical and in silico pathway analysis","volume":"68","author":"Magalh\u00e3es","year":"2024","journal-title":"Archives of Endocrinology and Metabolism"},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0120","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/s41598-021-81349-7","article-title":"Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0125","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40520-016-0636-0","article-title":"Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension","volume":"29","author":"Barma","year":"2017","journal-title":"Aging Clin. Exp. Res."},{"issue":"9","key":"10.1016\/j.cca.2026.120839_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092737","article-title":"A novel role of growth differentiation factor (GDF)-15 in overlap with sedentary lifestyle and cognitive risk in COPD","volume":"9","author":"Hirano","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0135","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s11357-023-00899-y","article-title":"Association of growth and differentiation factor-15 with coronary artery calcium score and ankle-brachial index in a middle-aged and elderly Caucasian population sample free of manifest cardiovascular disease","volume":"46","author":"Kiss","year":"2024","journal-title":"GeroScience"},{"issue":"2","key":"10.1016\/j.cca.2026.120839_bb0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejim.2011.08.022","article-title":"Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy","volume":"23","author":"Montoro-Garc\u00eda","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.cca.2026.120839_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/2519128","article-title":"GDF-15 is associated with poor physical function in prefrail older adults with diabetes","volume":"2023","author":"Merchant","year":"2023","journal-title":"J. Diabetes Res."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00011-019-01220-4","article-title":"The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis","volume":"68","author":"Mi","year":"2019","journal-title":"Inflamm. Res."},{"issue":"9","key":"10.1016\/j.cca.2026.120839_bb0155","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.15537\/smj.2025.46.9.20240753","article-title":"Serum levels of GDF-15, betatrophin, TNF-\u03b1 and IL-6 in diabetic patients with and without diabetic complications","volume":"46","author":"Y\u0131lmaz","year":"2025","journal-title":"Saudi Med. J."},{"issue":"12","key":"10.1016\/j.cca.2026.120839_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33044","article-title":"Correlations between growth differentiation factor 15 (GDF-15) serum levels and gene polymorphism with type 2 diabetes mellitus","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.cca.2026.120839_bb0165","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12020-021-02632-1","article-title":"Associations of GDF-15 and GDF-15\/adiponectin ratio with odds of type 2 diabetes in the Chinese population","volume":"72","author":"Wu","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2026.120839_bb0170","article-title":"Non-targeted metabolomics reveals the potential role of MFSD8 in metabolism in human endothelial cells","author":"Xiang","year":"2025","journal-title":"Mol. Biotechnol."},{"issue":"3","key":"10.1016\/j.cca.2026.120839_bb0175","first-page":"387","article-title":"[value of plasma growth differentiation factor-15 in diagnosis and evaluation of type 2 diabetic nephropathy], Nan fang yi ke da xue xue bao =","volume":"34","author":"Li","year":"2014","journal-title":"J. Southern Medical Univ."},{"issue":"11","key":"10.1016\/j.cca.2026.120839_bb0180","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/dc12-0180","article-title":"Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes","volume":"35","author":"Hellemons","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120839_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111427","article-title":"GDF-15 alleviates diabetic nephropathy via inhibiting NEDD4L-mediated IKK\/NF-\u03baB signalling pathways","volume":"128","author":"Zhang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cca.2026.120839_bb0190","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.2147\/DMSO.S454531","article-title":"Correlation between growth differentiation Factor-15 and peripheral neuropathy in patients with type 2 diabetes mellitus","volume":"17","author":"Li","year":"2024","journal-title":"Diabetes, Metabolic Syndrome and Obesity\u202f: Targets and Therapy"},{"key":"10.1016\/j.cca.2026.120839_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/jdr\/6959604","article-title":"Study on the correlation between GDF-15 levels and a diagnostic model for diabetic retinopathy","volume":"2025","author":"Lian","year":"2025","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cca.2026.120839_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.627395","article-title":"The relationship between circulating growth differentiation factor 15 levels and diabetic retinopathy in patients with type 2 diabetes","volume":"12","author":"Niu","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77584-z","article-title":"Relationship between plasma growth differentiation factor-15 levels and diabetic retinopathy in individuals with type 2 diabetes","volume":"10","author":"Chung","year":"2020","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.cca.2026.120839_bb0210","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021661","article-title":"Association between circulating GDF-15 and cardio-renal outcomes and effect of canagliflozin: results from the CANVAS trial","volume":"10","author":"Sen","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"7","key":"10.1016\/j.cca.2026.120839_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/biom12070934","article-title":"Major adverse cardiovascular events and mortality prediction by circulating GDF-15 in patients with type 2 diabetes: a systematic review and Meta-analysis","volume":"12","author":"Xie","year":"2022","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.cca.2026.120839_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101380","article-title":"Circulating levels of GDF-15 for predicting cardiovascular and cancer morbidity and mortality in type 2 diabetes: findings from Da Qing IGT and diabetes study","volume":"48","author":"Qian","year":"2022","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/03009734.2019.1696430","article-title":"Growth differentiation factor 15 (GDF-15) is a potential biomarker of both diabetic kidney disease and future cardiovascular events in cohorts of individuals with type 2 diabetes: a proteomics approach","volume":"125","author":"Carlsson","year":"2020","journal-title":"Ups. J. Med. Sci."},{"issue":"12","key":"10.1016\/j.cca.2026.120839_bb0230","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1373\/clinchem.2016.257212","article-title":"GDF-15 is associated with Cancer incidence in patients with type 2 diabetes","volume":"62","author":"Pavo","year":"2016","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0235","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdi.14404","article-title":"The effect of exercise on GDF-15 levels in individuals with prediabetes: a randomized controlled trial","volume":"16","author":"Y\u0131ld\u0131r\u0131m Ayaz","year":"2025","journal-title":"J. Diabetes Invest."},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0240","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1530\/EJE-12-0466","article-title":"Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial","volume":"167","author":"Kempf","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"25","key":"10.1016\/j.cca.2026.120839_bb0245","doi-asserted-by":"crossref","first-page":"41379","DOI":"10.18632\/oncotarget.17328","article-title":"Elevated serum growth differentiation factor 15 levels are associated with thyroid nodules in type 2 diabetes aged over 60 years","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2026.120839_bb0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fcvm.2020.00103","article-title":"Serum GDF15, a promising biomarker in obese patients undergoing heart surgery","volume":"7","author":"Sarkar","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.cca.2026.120839_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13071589","article-title":"Investigating the role of GDF-15 in diabetes and obesity: a comprehensive analysis of a cohort from the KDEP study","volume":"13","author":"Abubaker","year":"2025","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.cca.2026.120839_bb0260","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1373\/clinchem.2010.153726","article-title":"The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients","volume":"57","author":"Vila","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.120839_bb0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ebiom.2019.02.021","article-title":"Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: a mendelian randomization study","volume":"41","author":"Cheung","year":"2019","journal-title":"EBioMedicine"},{"issue":"14","key":"10.1016\/j.cca.2026.120839_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14144981","article-title":"The effects of a combined exercise intervention on body composition, GDF-15, Apelin-12, and IL-15 among older Korean women according to obesity status","volume":"14","author":"Kim","year":"2025","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12020-023-03435-2","article-title":"Alteration of BDNF, SPARC, FGF-21, and GDF-15 circulating levels after 1 year of anti-obesity treatments and their association with 1-year weight loss","volume":"82","author":"Chaiyasoot","year":"2023","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.cca.2026.120839_bb0280","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12845","article-title":"A 24-month metformin treatment study of children with obesity: changes in circulating GDF-15 and associations with changes in body weight and visceral fat","volume":"17","author":"Carreras-Badosa","year":"2022","journal-title":"Pediatr. Obes."},{"key":"10.1016\/j.cca.2026.120839_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155444","article-title":"Circulating Total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide and\/or Lorcaserin treatment in humans with obesity and\/or diabetes","volume":"142","author":"Valenzuela-Vallejo","year":"2023","journal-title":"Metab. Clin. Exp."},{"issue":"12","key":"10.1016\/j.cca.2026.120839_bb0290","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/ijo.2014.27","article-title":"NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism","volume":"38","author":"Chrysovergis","year":"2014","journal-title":"Int. J. Obes. (Lond) (2005)"},{"issue":"8","key":"10.1016\/j.cca.2026.120839_bb0295","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1007\/s00464-022-09036-w","article-title":"The effect of bariatric surgery on the expression of growth differentiation Factor-15\/macrophage-inhibitory Cytokine-1 (GDF-15\/MIC-1) in rat","volume":"36","author":"Dolo","year":"2022","journal-title":"Surg. Endosc."},{"issue":"2","key":"10.1016\/j.cca.2026.120839_bb0300","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40200-021-00828-w","article-title":"The impact of cichorium intybus L. on GDF-15 level in obese diabetic albino mice as compared with metformin effect","volume":"20","author":"Eltokhy","year":"2021","journal-title":"J. Diabetes Metab. Disord."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0305","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00774-013-0560-8","article-title":"Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome","volume":"33","author":"Berberoglu","year":"2015","journal-title":"J. Bone Miner. Metab."},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0310","doi-asserted-by":"crossref","first-page":"252","DOI":"10.5830\/CVJA-2010-013","article-title":"Effect of systemic hypertension on right ventricular morphology and function: an echocardiographic study","volume":"21","author":"Akintunde","year":"2010","journal-title":"Cardiovasc. J. Afr."},{"key":"10.1016\/j.cca.2026.120839_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123110","article-title":"Formononetin alleviates no reflow after myocardial ischemia-reperfusion via modulation of gut microbiota to inhibit inflammation","volume":"358","author":"Zhang","year":"2024","journal-title":"Life Sci."},{"issue":"Suppl. 3","key":"10.1016\/j.cca.2026.120839_bb0320","article-title":"Elevated growth and differentiation factor 15 (GDF-15) levels amplifies the association between home blood pressure variability and cardiovascular outcome","volume":"41","author":"Hoshide","year":"2023","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0325","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2217\/pme-2016-0030","article-title":"Elevated levels of GDF-15 is associated with increased angiotensin II in hypertensive patients with type 2 diabetes","volume":"13","author":"Adela","year":"2016","journal-title":"Pers. Med."},{"key":"10.1016\/j.cca.2026.120839_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1085122","article-title":"Correlation between serum GDF-15 level and pulmonary vascular morphological changes and prognosis in patients with pulmonary arterial hypertension","volume":"10","author":"Maimaiti","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"17","key":"10.1016\/j.cca.2026.120839_bb0335","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/bmm-2022-0395","article-title":"GDF-15 and soluble ST2 as biomarkers of right ventricular dysfunction in pulmonary hypertension","volume":"16","author":"Keranov","year":"2022","journal-title":"Biomark. Med"},{"key":"10.1016\/j.cca.2026.120839_bb0340","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.2147\/COPD.S429334","article-title":"Predictive value of GDF-15 and sST2 for pulmonary hypertension in acute exacerbation of chronic obstructive pulmonary disease","volume":"18","author":"Lv","year":"2023","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0345","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd10010022","article-title":"A story of PA\/BSA and biomarkers to diagnose pulmonary hypertension in patients with severe aortic valve stenosis-the rise of IGF-BP2 and GDF-15","volume":"10","author":"Kletzer","year":"2023","journal-title":"J. Cardiovasc Dev. Dis."},{"key":"10.1016\/j.cca.2026.120839_bb0350","article-title":"Growth differentiation Factor-15 improves prognostic accuracy of risk stratification in pulmonary arterial hypertension","author":"Wang","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.cca.2026.120839_bb0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2023.01.026","article-title":"Circulating GDF-15 in relation to the progression and prognosis of chronic kidney disease: a systematic review and dose-response meta-analysis","volume":"110","author":"Zhou","year":"2023","journal-title":"Eur. J. Intern. Med."},{"issue":"7","key":"10.1016\/j.cca.2026.120839_bb0360","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/1354750X.2020.1821776","article-title":"Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary hypertension","volume":"25","author":"Kriechbaum","year":"2020","journal-title":"Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals"},{"key":"10.1016\/j.cca.2026.120839_bb0365","series-title":"Expression of Growth Differentiation Factor 15 (GDF-15) in Placental Tissue of Full-Term Pregnant Women with Hypertensive Disorders in a Western Australian Population","author":"Chew","year":"2024"},{"issue":"10","key":"10.1016\/j.cca.2026.120839_bb0370","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015521","article-title":"GDF-15 (growth differentiation factor 15) is associated with hospitalization and mortality in patients with a Fontan circulation","volume":"9","author":"Meyer","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.cca.2026.120839_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104873","article-title":"Biomarkers of calcification, endothelial injury, and platelet-endothelial interaction in patients with aortic valve stenosis","volume":"26","author":"Ba\u0144ka","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0380","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/rheumatology\/keab277","article-title":"Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid syndrome","volume":"61","author":"Tektonidou","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0385","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12931-017-0521-1","article-title":"GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease","volume":"18","author":"Martinez","year":"2017","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0390","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13293-021-00393-0","article-title":"Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality","volume":"12","author":"Laucyte-Cibulskiene","year":"2021","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.cca.2026.120839_bb0395","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2016.02.013","article-title":"Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: the Framingham heart study","volume":"248","author":"Andersson","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2026.120839_bb0400","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijcard.2017.03.101","article-title":"Circulating GDF-15 levels predict future secondary manifestations of cardiovascular disease explicitly in women but not men with atherosclerosis","volume":"241","author":"Gohar","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2026.120839_bb0405","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/1755-5922.12184","article-title":"Increased serum level of growth differentiation factor 15 (GDF-15) is associated with coronary artery disease","volume":"34","author":"Wang","year":"2016","journal-title":"Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0410","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12933-020-01092-7","article-title":"Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease","volume":"19","author":"Li","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"38","key":"10.1016\/j.cca.2026.120839_bb0415","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000044530","article-title":"Effect of growth differentiation factor-15 (GDF-15) level on extent and severity of atherosclerosis in peripheral arterial disease patients free of obstructive coronary artery disease: a cross-sectional observational study","volume":"104","author":"Ozdemir","year":"2025","journal-title":"Medicine"},{"issue":"Suppl. 3","key":"10.1016\/j.cca.2026.120839_bb0420","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00059-014-4139-5","article-title":"Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis","volume":"40","author":"Yilmaz","year":"2015","journal-title":"Herz"},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0425","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2047-783X-18-19","article-title":"GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis","volume":"18","author":"Preusch","year":"2013","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.cca.2026.120839_bb0430","article-title":"GDF-15 suppresses atherosclerosis by inhibiting oxLDL-induced lipid accumulation and inflammation in macrophages","volume":"2021","author":"Huang","year":"2021","journal-title":"Evidence-Based Complementary and Alternative Medicine\u202f: eCAM"},{"issue":"10","key":"10.1016\/j.cca.2026.120839_bb0435","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1038\/s41401-025-01561-3","article-title":"Revisiting the role of GDF15 in atherosclerosis in mouse and human","volume":"46","author":"Liu","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cca.2026.120839_bb0440","first-page":"6","article-title":"Identification of potential molecular players and therapeutic drug molecules in melphalan resistant multiple myeloma by integrated bioinformatics analysis, research","volume":"17","author":"Vedeshachaitanya","year":"2022","journal-title":"J. Biotechnol."},{"issue":"2","key":"10.1016\/j.cca.2026.120839_bb0445","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00441-004-0986-3","article-title":"Involvement of growth differentiation factor-15\/macrophage inhibitory cytokine-1 (GDF-15\/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions","volume":"318","author":"Schlittenhardt","year":"2004","journal-title":"Cell Tissue Res."},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0450","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/ehf2.14484","article-title":"GDF-15 at admission predicts cardiovascular death, heart failure, and bleeding outcomes in patients with CAD","volume":"10","author":"Wang","year":"2023","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.cca.2026.120839_bb0455","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.resuscitation.2020.05.001","article-title":"GDF-15 is associated with sudden cardiac death due to incident myocardial infarction","volume":"152","author":"Andersson","year":"2020","journal-title":"Resuscitation"},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0460","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12872-020-01744-2","article-title":"The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample mendelian randomization study","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Cardiovasc. Disord."},{"issue":"8","key":"10.1016\/j.cca.2026.120839_bb0465","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glae163","article-title":"Growth differentiation factor 15 as a biomarker of cardiovascular risk in chronic musculoskeletal pain","volume":"79","author":"Le\u00f3n-Gonz\u00e1lez","year":"2024","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0470","doi-asserted-by":"crossref","first-page":"460","DOI":"10.5937\/jomb0-24662","article-title":"Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome","volume":"39","author":"Vasanthi","year":"2020","journal-title":"J. Medical Biochemistry"},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0475","first-page":"210","article-title":"Growth differentiation factor-15 is a prognostic marker in patients with intermediate coronary artery disease","volume":"17","author":"Wang","year":"2020","journal-title":"J. Geriatric Cardiology : JGC"},{"issue":"7","key":"10.1016\/j.cca.2026.120839_bb0480","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11239-024-03019-5","article-title":"Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study","volume":"57","author":"Lyu","year":"2024","journal-title":"J. Thromb. Thrombolysis"},{"issue":"7","key":"10.1016\/j.cca.2026.120839_bb0485","doi-asserted-by":"crossref","first-page":"527","DOI":"10.26599\/1671-5411.2023.07.007","article-title":"Growth differentiation factor 15 predicts cardiovascular events in stable coronary artery disease","volume":"20","author":"Wang","year":"2023","journal-title":"J. Geriatric Cardiology : JGC"},{"issue":"8","key":"10.1016\/j.cca.2026.120839_bb0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105759","article-title":"Growth differentiation factor-15 (GDF-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass","volume":"9","author":"Kahli","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.120839_bb0495","series-title":"Association between Growth Differentiation Factor-15 and Coagulation Parameters in Male Chinese Coronary Artery Disease Patients","author":"Liu","year":"2025"},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0500","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12933-019-0823-3","article-title":"Potential relation between soluble growth differentiation factor-15 and testosterone deficiency in male patients with coronary artery disease","volume":"18","author":"Liu","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"10.1016\/j.cca.2026.120839_bb0505","doi-asserted-by":"crossref","first-page":"148","DOI":"10.21315\/mjms2024.31.6.12","article-title":"Elevated inflammation and adhesion molecule hsCRP, GDF-15 and VCAM-1 in angina patients with non-obstructive coronary artery disease","volume":"31","author":"Sanip","year":"2024","journal-title":"The Malaysian J. Medical Sci: MJMS"},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0510","doi-asserted-by":"crossref","DOI":"10.31083\/RCM38504","article-title":"Cardiometabolic dysregulation and heart failure","volume":"26","author":"Ashfield","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0515","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/clinchem\/hvaa332","article-title":"Growth differentiation factor (GDF)-15 and cardiometabolic outcomes among older adults: the atherosclerosis risk in communities study","volume":"67","author":"Echouffo-Tcheugui","year":"2021","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.120839_bb0520","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.2147\/DDDT.S282206","article-title":"Xanthohumol inhibits TGF-\u03b21-induced cardiac fibroblasts activation via mediating PTEN\/Akt\/mTOR Signaling pathway","volume":"14","author":"Jiang","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.cca.2026.120839_bb0525","series-title":"Associations of Serum GDF-15 Levels with Physical Performance, Mobility Disability, Cognition, Cardiovascular Disease, and Mortality in Older Adults, medRxiv\u202f: The Preprint Server for Health Sciences","author":"Webber","year":"2024"},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0530","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12872-021-02138-8","article-title":"IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study","volume":"21","author":"Meessen","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.cca.2026.120839_bb0535","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2018.10.023","article-title":"Calcitonin gene-related peptide inhibits the cardiac fibroblasts senescence in cardiac fibrosis via up-regulating klotho expression","volume":"843","author":"Li","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0540","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2018.03.025","article-title":"GDF-15, galectin 3, soluble ST2, and risk of mortality and cardiovascular events in CKD","volume":"72","author":"Tuegel","year":"2018","journal-title":"American J. Kidney Diseases\u202f: Official J. National Kidney Foundation"},{"key":"10.1016\/j.cca.2026.120839_bb0545","series-title":"Plasma Metabolomic and Growth Differentiation Factor-15 (GDF-15) in Chronic Heart Failure with Physical Frailty","author":"Prokopidis","year":"2025"},{"key":"10.1016\/j.cca.2026.120839_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116337","article-title":"The Janus face of mitophagy in myocardial ischemia\/reperfusion injury and recovery","volume":"173","author":"Deng","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cca.2026.120839_bb0555","article-title":"Association between serum GDF-15, myostatin, and sarcopenia in cardiovascular surgery patients","volume":"42","author":"Nishikawa","year":"2022","journal-title":"Int. J. Cardiol. Heart. Vasc."},{"issue":"6","key":"10.1016\/j.cca.2026.120839_bb0560","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/rheumatology\/keaa721","article-title":"The diagnostic value of GDF-15 for myocardial involvement in idiopathic inflammatory myopathy","volume":"60","author":"Qiu","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.cca.2026.120839_bb0565","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8070924","article-title":"New cardiovascular biomarkers in ischemic heart disease-GDF-15, a probable predictor for ejection fraction","volume":"8","author":"Dalos","year":"2019","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.cca.2026.120839_bb0570","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.amjcard.2014.06.020","article-title":"Usefulness of growth differentiation factor-15 levels to predict diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes mellitus","volume":"114","author":"Dominguez-Rodriguez","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"Supplement_2","key":"10.1016\/j.cca.2026.120839_bb0575","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.2558","article-title":"Association of GDF15, NTpoBNP and PLGF with subclinical cardiac dysfunction in type 2 diabetes: effects of novel antidiabetic treatment","volume":"44","author":"Ikonomidis","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0580","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12872-024-03802-5","article-title":"GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome","volume":"24","author":"Kosum","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3","key":"10.1016\/j.cca.2026.120839_bb0585","first-page":"674","article-title":"GDF-15, Galectin-3, and sST2 as biomarkers for right ventricular dysfunction in patients with pulmonary arterial hypertension: a systematic review","volume":"11","author":"Yanni","year":"2025","journal-title":"J. Appl. Bioanalysis"},{"issue":"6","key":"10.1016\/j.cca.2026.120839_bb0590","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70132","article-title":"Metabolic dysfunction-associated Steatotic liver disease (MASLD): mechanisms, clinical implications and therapeutic advances","volume":"8","author":"Miller","year":"2025","journal-title":"Endocrinology, Diabetes & Metabolism"},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0595","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41387-021-00170-3","article-title":"Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD","volume":"11","author":"Bilson","year":"2021","journal-title":"Nutr. Diabetes"},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0600","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/liv.13587","article-title":"Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease","volume":"38","author":"Koo","year":"2018","journal-title":"Liver Int: Official J. Int. Association for the Study of the Liver"},{"issue":"5","key":"10.1016\/j.cca.2026.120839_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052039","article-title":"GDF15 circulating levels are associated with metabolic-associated liver injury and atherosclerotic cardiovascular disease","volume":"26","author":"Girona","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41387-022-00187-2","article-title":"Growth differentiation factor 15 (GDF15) is associated with non-alcoholic fatty liver disease (NAFLD) in youth with overweight or obesity","volume":"12","author":"Galuppo","year":"2022","journal-title":"Nutr. Diabetes"},{"issue":"13","key":"10.1016\/j.cca.2026.120839_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136486","article-title":"Levels of growth differentiation factor 15 correlated with metabolic dysfunction-associated Steatotic liver disease in children","volume":"26","author":"Mosca","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0620","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.1038\/s41467-024-51078-2","article-title":"Adipose tissue macrophage infiltration and hepatocyte stress increase GDF-15 throughout development of obesity to MASH","volume":"15","author":"L\u2019Homme","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cca.2026.120839_bb0625","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.bbrc.2017.08.096","article-title":"Hepatic GDF15 is regulated by CHOP of the unfolded protein response and alleviates NAFLD progression in obese mice","volume":"498","author":"Li","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0630","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1038\/s41598-018-25098-0","article-title":"Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.cca.2026.120839_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078797","article-title":"GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men","volume":"8","author":"Wallentin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2026.120839_bb0640","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.1169","article-title":"Elevated GDF-15 levels may indicate malnutrition in chronic compensated heart failure with or without diabetes mellitus","volume":"41","author":"Xie","year":"2020","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0645","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.70011","article-title":"Association of Difference between eGFR from cystatin C and creatinine and serum GDF-15 with adverse outcomes in diabetes mellitus","volume":"16","author":"Gohda","year":"2025","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.cca.2026.120839_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196634","article-title":"Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study","volume":"13","author":"Frimodt-M\u00f8ller","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2026.120839_bb0655","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3892\/etm.2023.12126","article-title":"Growth differentiation factor-15 in patients with gestational diabetes mellitus and its relationship with microalbuminuria","volume":"26","author":"Gong","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"15","key":"10.1016\/j.cca.2026.120839_bb0660","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1177\/2047487317725017","article-title":"GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction","volume":"24","author":"Skau","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.cca.2026.120839_bb0665","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12933-016-0375-8","article-title":"Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study","volume":"15","author":"Farhan","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"10.1016\/j.cca.2026.120839_bb0670","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCGENETICS.108.824870","article-title":"Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study","volume":"2","author":"Kempf","year":"2009","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.cca.2026.120839_bb0675","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.1577","article-title":"Plasma levels of human growth differentiation factor 15 (GDF-15) and their effect of alirocumab on major adverse cardiovascular events and all-cause death after acute coronary syndrome","volume":"45","author":"Jukema","year":"2024","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0680","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12944-023-01792-5","article-title":"Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia","volume":"22","author":"Cheng","year":"2023","journal-title":"Lipids Health Dis."},{"issue":"11","key":"10.1016\/j.cca.2026.120839_bb0685","first-page":"1273","article-title":"[GDF-15 in plasma and circulating mononuclear cells and NT-proBNP for diagnosis of chronic heart failure and predicting cardiovascular disease events], Nan fang yi ke da xue xue bao =","volume":"39","author":"Xiangrui","year":"2019","journal-title":"J. Southern Medical Univ."},{"issue":"1","key":"10.1016\/j.cca.2026.120839_bb0690","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.009526","article-title":"Multimarker analysis of serially measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, creatinine, and prognosis in acute heart failure","volume":"16","author":"G\u00fcrg\u00f6ze","year":"2023","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.cca.2026.120839_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12061330","article-title":"Importance of T1-mapping sequence in patients with hypertrophic cardiomyopathy without foci of non-ischemic myocardial injury in late gadolinium enhancement sequence","volume":"12","author":"Zdebik","year":"2024","journal-title":"Biomedicines"},{"issue":"39","key":"10.1016\/j.cca.2026.120839_bb0700","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034675","article-title":"GDF-15 (a biomarker for metformin) and the risk of COVID-19: a two-sample mendelian randomization study","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2026.120839_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2024.1414866","article-title":"Circulating GDF-15: a biomarker for metabolic dysregulation and aging in people living with HIV","volume":"5","author":"Wang","year":"2024","journal-title":"Frontiers in Aging"},{"issue":"12","key":"10.1016\/j.cca.2026.120839_bb0710","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005594","article-title":"GDF-15 (growth differentiation factor 15) is associated with lack of ventricular recovery and mortality after transcatheter aortic valve replacement","volume":"10","author":"Kim","year":"2017","journal-title":"Circulation. Cardiovascular Interventions"},{"issue":"11","key":"10.1016\/j.cca.2026.120839_bb0715","first-page":"21201","article-title":"Growth differentiation factor-15 (GDF-15), novel biomarker for assessing atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease","volume":"8","author":"Zhou","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"8","key":"10.1016\/j.cca.2026.120839_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231234","article-title":"The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: characterization of the model and cardioprotective effect of GDF15","volume":"15","author":"Stolina","year":"2020","journal-title":"PLoS One"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:27:48Z","timestamp":1793640468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":144,"alternative-id":["S0009898126000215"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120839","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GDF-15 as an integrative cardiometabolic biomarker","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120839"}}